BACKGROUND: Phytanic acid, a fatty acid predominantly obtained from foods high in ruminant fat, may have a biological role in the up-regulation of the protein alpha-methylacyl-coenzyme A racemase, which is overexpressed in prostate cancer tissue. OBJECTIVE: This study aimed to examine the association between plasma concentrations of phytanic acid and subsequent risk of prostate cancer. DESIGN: Within the European Prospective Investigation into Cancer and Nutrition cohort, 566 incident prostate cancer cases from Germany, Greece, Italy, the Netherlands, Spain, and the United Kingdom were individually matched to 566 controls by study center, age at recruitment, and time of day and duration of fasting at blood collection. Phytanic acid concentrations were measured by using a gas chromatography-mass spectrometry assay. RESULTS: In controls, plasma phytanic acid concentration was strongly correlated with dairy fat intake (r = 0.49, P < 0.0001), varied significantly by country (P for heterogeneity < 0.0001), and decreased with age (P for trend = 0.02) and duration of fasting at blood collection (P for trend = 0.002). There was no significant association of phytanic acid with prostate cancer risk overall (odds ratio for a doubling in concentration: 1.05; 95% CI: 0.91, 1.21; P for trend = 0.53) or by stage or grade of disease. However, in men who had fasted (>3 h) at blood collection, the odds ratio for prostate cancer was 1.27 (95% CI: 1.01, 1.60; P for trend = 0.04). CONCLUSION: Plasma phytanic acid concentration is significantly associated with intake of dairy fat but not with overall risk of prostate cancer in this European population.
BACKGROUND: Phytanic acid, a fatty acid predominantly obtained from foods high in ruminant fat, may have a biological role in the up-regulation of the protein alpha-methylacyl-coenzyme A racemase, which is overexpressed in prostate cancer tissue. OBJECTIVE: This study aimed to examine the association between plasma concentrations of phytanic acid and subsequent risk of prostate cancer. DESIGN: Within the European Prospective Investigation into Cancer and Nutrition cohort, 566 incident prostate cancer cases from Germany, Greece, Italy, the Netherlands, Spain, and the United Kingdom were individually matched to 566 controls by study center, age at recruitment, and time of day and duration of fasting at blood collection. Phytanic acid concentrations were measured by using a gas chromatography-mass spectrometry assay. RESULTS: In controls, plasma phytanic acid concentration was strongly correlated with dairy fat intake (r = 0.49, P < 0.0001), varied significantly by country (P for heterogeneity < 0.0001), and decreased with age (P for trend = 0.02) and duration of fasting at blood collection (P for trend = 0.002). There was no significant association of phytanic acid with prostate cancer risk overall (odds ratio for a doubling in concentration: 1.05; 95% CI: 0.91, 1.21; P for trend = 0.53) or by stage or grade of disease. However, in men who had fasted (>3 h) at blood collection, the odds ratio for prostate cancer was 1.27 (95% CI: 1.01, 1.60; P for trend = 0.04). CONCLUSION: Plasma phytanic acid concentration is significantly associated with intake of dairy fat but not with overall risk of prostate cancer in this European population.
Authors: Panagiota N Mitrou; Demetrius Albanes; Stephanie J Weinstein; Pirjo Pietinen; Philip R Taylor; Jarmo Virtamo; Michael F Leitzmann Journal: Int J Cancer Date: 2007-06-01 Impact factor: 7.396
Authors: A S Whittemore; L N Kolonel; A H Wu; E M John; R P Gallagher; G R Howe; J D Burch; J Hankin; D M Dreon; D W West Journal: J Natl Cancer Inst Date: 1995-05-03 Impact factor: 13.506
Authors: Carmen Rodriguez; Marjorie L McCullough; Alison M Mondul; Eric J Jacobs; Dorna Fakhrabadi-Shokoohi; Edward L Giovannucci; Michael J Thun; Eugenia E Calle Journal: Cancer Epidemiol Biomarkers Prev Date: 2003-07 Impact factor: 4.254
Authors: P H Gann; C H Hennekens; F M Sacks; F Grodstein; E L Giovannucci; M J Stampfer Journal: J Natl Cancer Inst Date: 1994-02-16 Impact factor: 13.506
Authors: Chandan Kumar-Sinha; Rajal B Shah; Bharathi Laxman; Scott A Tomlins; Jason Harwood; Werner Schmitz; Ernst Conzelmann; Martin G Sanda; John T Wei; Mark A Rubin; Arul M Chinnaiyan Journal: Am J Pathol Date: 2004-03 Impact factor: 4.307
Authors: N E Allen; T J Key; P N Appleby; R C Travis; A W Roddam; A Tjønneland; N F Johnsen; K Overvad; J Linseisen; S Rohrmann; H Boeing; T Pischon; H B Bueno-de-Mesquita; L Kiemeney; G Tagliabue; D Palli; P Vineis; R Tumino; A Trichopoulou; C Kassapa; D Trichopoulos; E Ardanaz; N Larrañaga; M-J Tormo; C A González; J R Quirós; M-J Sánchez; S Bingham; K-T Khaw; J Manjer; G Berglund; P Stattin; G Hallmans; N Slimani; P Ferrari; S Rinaldi; E Riboli Journal: Br J Cancer Date: 2008-04-01 Impact factor: 7.640
Authors: Yan Song; Jorge E Chavarro; Yin Cao; Weiliang Qiu; Lorelei Mucci; Howard D Sesso; Meir J Stampfer; Edward Giovannucci; Michael Pollak; Simin Liu; Jing Ma Journal: J Nutr Date: 2012-12-19 Impact factor: 4.798
Authors: Jonathan L Wright; Marian L Neuhouser; Daniel W Lin; Erika M Kwon; Ziding Feng; Elaine A Ostrander; Janet L Stanford Journal: Prostate Date: 2010-10-13 Impact factor: 4.104
Authors: Nicholas J Ollberding; Briseis Aschebrook-Kilfoy; Donne Bennett D Caces; Margaret E Wright; Dennis D Weisenburger; Sonali M Smith; Brian C-H Chiu Journal: Carcinogenesis Date: 2012-10-05 Impact factor: 4.944
Authors: Yachana Kataria; Margaret Wright; Ryan J Deaton; Erika Enk Rueter; Benjamin A Rybicki; Ann B Moser; Vijayalakshmi Ananthanrayanan; Peter H Gann Journal: Prostate Date: 2014-10-13 Impact factor: 4.104
Authors: Louise B Werner; Lars I Hellgren; Marianne Raff; Søren K Jensen; Rikke A Petersen; Tue Drachmann; Tine Tholstrup Journal: Lipids Health Dis Date: 2011-06-10 Impact factor: 3.876
Authors: Margaret E Wright; Demetrius Albanes; Ann B Moser; Stephanie J Weinstein; Kirk Snyder; Satu Männistö; Peter H Gann Journal: Cancer Med Date: 2014-08-16 Impact factor: 4.452
Authors: Aurora Perez-Cornago; Inge Huybrechts; Paul N Appleby; Julie A Schmidt; Francesca L Crowe; Kim Overvad; Anne Tjønneland; Tilman Kühn; Verena Katzke; Antonia Trichopoulou; Anna Karakatsani; Eleni Peppa; Sara Grioni; Domenico Palli; Carlotta Sacerdote; Rosario Tumino; H Bas Bueno-de-Mesquita; Nerea Larrañaga; Maria-Jose Sánchez; J Ramón Quirós; Eva Ardanaz; María-Dolores Chirlaque; Antonio Agudo; Anders Bjartell; Peter Wallström; Veronique Chajes; Konstantinos K Tsilidis; Dagfinn Aune; Elio Riboli; Ruth C Travis; Timothy J Key Journal: Int J Cancer Date: 2019-03-14 Impact factor: 7.396